UNSPSC 51162356: Naproxen/pseudoephedrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

UNSPSC 51162356 Naproxen/pseudoephedrine is a Commodity code that in recent state and local procurement activity encompasses naloxone, drug deactivation systems, and generic multi-source pharmaceuticals and over-the-counter products supplied to public health agencies, county health departments, and participating state and local government facilities. The code's nominal scope does not align closely with the recent opportunities being tagged under it — the two visible solicitations involve naloxone and emergency-response pharmaceuticals rather than naproxen/pseudoephedrine combination products — suggesting either a cataloging inconsistency in how state and local buyers are tagging these purchases or that the code is being used as a catch-all for pharmaceutical and OTC product procurement more broadly. Issuing bodies include county health departments (Seminole County, Florida) and multistate cooperative purchasing alliances (MMCAP, administered by the Minnesota Department of Administration's Office of State Procurement on behalf of participating states including Oregon). Requirements typically include cGMP and Drug Supply Chain Security Act compliance, authorized wholesaler relationships, EDI capability, comprehensive insurance coverage, and E-Verify employment verification.

Geographic activity concentrates in Florida and the Upper Midwest (Minnesota and participating cooperative members), with the multistate cooperative vehicle suggesting broader regional reach across MMCAP's member jurisdictions. Representative recent opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026; due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026; due March 26, 2026) establishing multiple contracts for generic pharmaceuticals and OTC products across state and local government facilities, with awarded vendors effective July 1, 2026. The cooperative procurement structure and emphasis on price competitiveness and wholesaler relationships suggest that vendors should be prepared for volume-based contracts, administrative fee structures (MMCAP charges 3 percent), and performance penalties for reporting or delivery failures.